- -11%
- New
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
Superbolan 400 is Dragon Pharma's high-concentration all-enanthate triple blend at 400mg/ml β combining Trenbolone Enanthate, Testosterone Enanthate and Drostanolone Enanthate in a single 10ml MCT oil vial. The same three compounds as Cut Long 300, at a higher total concentration that reduces injection volume by 25% per equivalent weekly dose β a meaningful practical advantage at the typical advanced cutting stack weekly doses of 600-800mg total.
Also searched as: Superbolan 400, Tren E Test E Masteron E blend 400mg, triple enanthate cutting blend, Superbolan Dragon Pharma.
The pharmacological case for an all-enanthate cutting blend is the same as for Cut Long 300 β and the rationale is worth explaining in full for users encountering this type of blend for the first time:
These two blends contain the same active compounds. The meaningful differences are concentration and the implied ratio per ml:
| Parameter | Superbolan 400 | Cut Long 300 |
|---|---|---|
| Total concentration | 400 mg/ml | 300 mg/ml |
| Per-compound (estimated) | ~133 mg/ml each | 100 mg/ml each |
| Volume for 600mg/week | 1.5 ml/week (0.75ml per injection) | 2 ml/week (1ml per injection) |
| Volume for 800mg/week | 2 ml/week (1ml per injection) | 2.67 ml/week (~1.33ml per injection) |
| 10ml vial total content | 4,000 mg | 3,000 mg |
| Esters | All Enanthate | All Enanthate |
| Twice-weekly injection | Yes | Yes |
At 800mg/week β a common advanced cutting dose for this three-compound stack β Superbolan 400 delivers this in just 1ml per twice-weekly injection. The same dose with Cut Long 300 requires 1.33ml per injection. At higher doses (1,000mg+/week), the injection volume difference becomes more meaningful for single-site comfort. Superbolan 400 delivers more compound per ml, making it the more efficient choice when running this specific combination at doses above 600mg/week.
| Component | Estimated Amount | Primary Role |
|---|---|---|
| Trenbolone Enanthate | ~133 mg/ml | Primary anabolic β lean mass, fat oxidation, strength; no aromatisation |
| Testosterone Enanthate | ~133 mg/ml | Androgenic base β hormonal wellbeing, libido support; aromatises (AI as needed) |
| Drostanolone Enanthate | ~133 mg/ml | Hardness + internal AI β SHBG binding, aromatase inhibition of Test component, dry physique |
The Drostanolone (Masteron) component at 133mg/ml partially manages the estrogen from Testosterone Enanthate through its intrinsic aromatase inhibitory activity β reducing but not eliminating the need for an external AI. At higher total doses (1ml+ twice weekly), additional estrogen management from Arimidex or Aromasin may be required for the testosterone component.
| Experience Level | Weekly Dose | Volume at 400mg/ml | Frequency | Cycle Length |
|---|---|---|---|---|
| Advanced (first use) | 600 mg/week | 1.5 ml/week | Twice weekly (0.75ml) | 10β14 weeks |
| Advanced high-dose | 800β1,000 mg/week | 2β2.5 ml/week | Twice weekly (1β1.25ml) | 10β12 weeks |
Superbolan 400 is an advanced compound β the Trenbolone Enanthate component requires prior Trenbolone experience. Start at 600mg/week to assess response from all three compounds before escalating. Cabergoline is recommended alongside for the Trenbolone 19-nor prolactin effects. PCT begins 14-21 days after the last injection.